S'abonner

Airway dysfunction and IgA immunity in COVID-unrelated and COVID-related ARDS - 17/02/23

Doi : 10.1016/j.rmr.2022.11.050 
L. Gerard 1, 2, , M. Lecocq 1, D. Hoton 4, C. Bouzin 1, P.F. Laterre 2, C. Pilette 1, 3
1 Institut de recherche expérimentale et clinique, université catholique de Louvain, Brussels, Belgium 
2 Department of intensive care, cliniques universitaires Saint-Luc, Brussels 
3 Department of pulmonary medicine, cliniques universitaires Saint-Luc, Brussels 
4 Department of anatomopathology, cliniques universitaires Saint-Luc, Brussels 

Corresponding author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Résumé

Introduction

Airway dysfunction and airway morphological changes have been reported in ARDS patients, and were associated with adverse outcomes [1]. However, airway functionality has been poorly characterized during ARDS, particularly in terms of IgA immunity, one of the frontline protection of the lung against pathogens. Besides, airway functionality and morphology have never been compared between COVID-unrelated ARDS and COVID-related ARDS (CARDS). Our objective was to assess the structure and functionality (with a specific focus on IgA immunity) of distal airways in patients with ARDS and with CARDS.

Methods

Samples of lung tissue from patients with ARDS (n=25), CARDS (n=18) and controls (n=15) were retrospectively compared in terms of morphological changes in distal airways. Broncho-epithelial functionality and IgA immunity were studied and quantified in a selected subset of lung samples by multiplex fluorescence immunohistochemistery. Production of Secretory Component (SC, the extracellular part of the Polymeric Immunoglobulin Receptor [pIgR], the carrier of IgA through the airway epithelium), IgAs, secretory (S) IgAs (IgA linked to SC) were prospectively assessed in the broncho-alveolar lavage (BAL) fluid from controls (n=5) and from patients with ARDS (n=24) as well as in the blood of controls (n=5), patients with CARDS (n=89) and with ARDS (n=24).

Results

In comparison with controls, airways of ARDS and CARDS patients were characterized by increased epithelial denudation (P=0.0078 and P<0.0001) and increased epithelial inflammation, mainly with neutrophils (P<0.0001). The tissue expression of pIgR (Fig. 1) was significantly lower in patients with ARDS in comparison with controls (P=0.048) and with CARDS (P=0.0052). The expression of S-IgA was selectively lower in ARDS compared with CARDS (P=0.023) whereas there was no difference in terms of IgA expression. Besides, the concentrations of the Secretory component (SC), IgAs and S-IgAs in BAL fluid were not different between ARDS and controls. Conversely, SC, S-IgA1 and S-IgA2 serum concentrations were increased in both ARDS and CARDS compared with controls (P<0.0001 and P=0.002; P<0.0001 and P=0.0005; P=0.0025 and P=0.0465 respectively), the increase being significantly larger in ARDS than in CARDS for s-IgA1 (P=0.0039) and SC (P=0.0022). There was no difference in serum concentrations of IgAs, suggesting that the observed increase in S-IgAs and SC reflected a conCtamination of the blood from the airway lumen through a damaged epithelium.

Conclusions

Structural and inflammatory changes in distal airways of patients with ARDS and CARDS were identified. A specific pattern of airway epithelial dysfunction and defective IgA epithelial transport was suggested in ARDS unrelated to COVID-19.

Le texte complet de cet article est disponible en PDF.

Plan


© 2022  Publié par Elsevier Masson SAS.
Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 40 - N° 2

P. 134-135 - février 2023 Retour au numéro
Article précédent Article précédent
  • Comparaison des effets anti-inflammatoires des corticoïdes classiques et dissociés (SEGRAMs) sur macrophages pulmonaires humains
  • M. Brollo, H. Salvator, E. Naline, S. Grassin-Delyle, P. Devillier
| Article suivant Article suivant
  • Effectiveness of non-invasive ventilation in acute respiratory failure by Covid-19 at Befelatanana hospital Antananarivo
  • F.P.P. Andriamahenina, M. Tiaray Harison, A.M. Nandimbiniaina, L. Rebasy, F.A. Martin, S.M. Razafimpihanina, A.Z. Razafindrasoa, D.O. Andriarimanga, O.F. Rakotondrasoa, K. Ravahatra, J.R. Rakotomizao, J.L. Rakotoson, R.N. Raharimanana